Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 April 2025 - 10:51

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/reblozyl

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters